Sovereign AI for Pharma: Protecting IP and GxP Record Integrity

Sovereign AI for pharma and life sciences means running advanced models on hardware the organisation owns and controls, so research intellectual property and GxP records never leave the building. It keeps trade secrets off third-party clouds, and it writes every action to a tamper-evident audit trail that supports data integrity expectations such as the ALCOA principles. The result is capability without exposure: the science stays private, and the record stays trustworthy.

• Sovereign AI runs on hardware the organisation owns, so sensitive research and manufacturing data stay on site.
• Valuable R&D intellectual property and trade secrets are never handed to a third-party cloud service.
• Every action is captured to a tamper-evident Open Audit Record that supports data integrity.
• The ALCOA principles ask that records be attributable, legible, contemporaneous, original and accurate.
• The Mickai closed beta is selective and open to design partners at mickai.co.uk/beta.

Why does pharma need sovereign AI rather than a public cloud service?

Pharmaceutical and life sciences work turns on information that is expensive to create and easy to lose: compound libraries, assay data, clinical datasets, formulation know-how and manufacturing parameters. Sending that material to a general-purpose cloud service means trusting an external operator with the crown jewels, and accepting that copies may sit in places the organisation cannot see or govern.

Sovereign AI reverses that arrangement. The models run where the data already lives, inside the organisation's own infrastructure, so the science is analysed in place rather than shipped out. Capability arrives without the sponsor, the contract manufacturer or the research site giving up control of what matters most.

How does sovereign AI protect R&D intellectual property and trade secrets?

Trade secrets only hold value while they stay secret. The moment a molecule, a process or a dataset is uploaded to someone else's environment, protection depends on that vendor's controls, staff and jurisdiction rather than on the organisation's own.

Running AI on owned, offline hardware keeps the boundary intact. Prompts, documents and results are processed locally, so nothing is silently retained, mined for training or exposed through a shared service. The organisation can prove where its intellectual property has been, because it never left.

What is data integrity, and how do the ALCOA principles apply?

Data integrity is the assurance that a record is complete, consistent and trustworthy across its whole life. In GxP settings it is often summarised by the ALCOA principles: records should be attributable to the person who made them, legible, contemporaneous, original and accurate.

AI raises the stakes because it can generate, summarise and transform records at speed. If those outputs feed regulated processes, the organisation needs to show who did what, when, and against which source. Sovereign AI keeps that provenance close, rather than scattering it across external systems it cannot inspect.

How does a tamper-evident audit trail support GxP records?

A tamper-evident audit trail records each action in a way that makes later alteration detectable. It does not claim to be tamper-proof: instead, it gives reviewers and auditors a dependable way to see whether a record has been changed since it was written.

That property maps directly onto data integrity needs. When every model interaction, document edit and approval is captured contemporaneously and attributably, the audit trail becomes evidence rather than assertion. A tamper-evident audit trail suits data-integrity needs precisely because it turns trust into something that can be checked.

How does the Mickai SIOS run inside a life sciences organisation?

Mickai is a SIOS, a sovereign intelligence operating system, built by founder Micky Irons to run advanced AI on an organisation's own hardware: owned, offline and provable. The approach is backed by 104 filed UK patent applications, approximately 2,340 claims, owned by Mickai LTD. Research and manufacturing data stay on site, and every action is written to the tamper-evident Open Audit Record so the work is captured as it happens.

The Mickai closed beta is open to a selective group of design partners who want to shape how sovereign AI serves pharma and life sciences. It is not offered to everyone, and places are decided by fit rather than by volume. Organisations interested in taking part can apply at mickai.co.uk/beta. None of this is regulatory or legal advice, and each organisation remains responsible for validating its own regulated processes.

Frequently asked questions

Is my research data used to train external models?

No. On a sovereign deployment, models run on hardware the organisation owns, so prompts, documents and results are processed on site. Nothing is sent to a third-party service to be retained or used for training, and the organisation can demonstrate that its data never left its own environment.

Does a tamper-evident audit trail make my records impossible to change?

No. Tamper-evident means alteration can be detected, not that change is impossible. The value is evidential: reviewers and auditors can see whether a record has been modified since it was written, which is what data integrity work actually depends on.

Can sovereign AI still work if our sites are offline or air-gapped?

Yes. Running on owned hardware means the system does not rely on a live connection to an external cloud. That suits research and manufacturing environments where connectivity is restricted, and it keeps sensitive information inside the organisation's own boundary.

How does this relate to the ALCOA principles?

The ALCOA principles ask that records be attributable, legible, contemporaneous, original and accurate. Capturing each action contemporaneously and attributably to the tamper-evident Open Audit Record supports those expectations, though every organisation remains responsible for validating its own regulated processes.

How do I apply for the Mickai closed beta?

Applications are made at mickai.co.uk/beta. The beta is selective and aimed at design partners in pharma and life sciences, so not every applicant is accepted. Places are decided by fit rather than by any fixed number.